| Abstrakt: |
Diabetes patients often have a reduced immune response; thus, management of infectious diseases in diabetes patients is very important, in the present study, we investigated the medical treatment between diabetes and dermatophytosis. To analyze such medication, we have surveying clinical report from the view point of name of drug, amount of drug, and period of medication. We enrolled 358 patients who were treated in Japanese Red Cross Saitama Hospital and surveyed their therapeutic drug use for one year from April 1, 2015 to March 31, 2016. On comparing data of dermatophytosis patients with and without diabetes, we found that drug use and amount of drug were similar between the two groups; no characteristic medicines were identified for any one group. In contrast, the number of visits to the hospital was significantly high among dermatophytosis patients without diabetes (tinea pedis, P <0.05; toenail tinea, P <0.01). Patients with diabetes had low medical knowledge nevertheless supporting patient education programs in the hospital. Thus, performance of patients for their own medication and motivation of continuing medication are low and poor. Such patients also had less medical knowledge about dermatophytosis; thus, active drug therapy and continuation of therapy were difficult Based on these findings, we strongly suggested that effective consultation in collaboration with medical doctors and nurses is needed for diabetes patients. With such a collaboration, the pharmacist can strongly support basic skin and foot care management along with providing consultation for proper drug use. [ABSTRACT FROM AUTHOR] |
